Age Problem
Conditions
Keywords
Gingivitis, Periodontal treatment
Brief summary
The aim of this study will evaluate the effectiveness of 0.12% chlorhexidine solution as an anti-inflammatory agent and reducing the presence of biofilm in young adults.
Detailed description
Thirty patients with gingivitis ages 18 to 30 year with a probing depth of at most 3 mm and at least 20 teeth will be selected and evaluate at baseline and after 4 weeks.
Interventions
the patients were randomly allocated into two groups of 15 individuals to rinse with antimicrobials twice a day for a period of four weeks. Group A, received 0.12% chlorhexidine antimicrobian in a vial previously identified as solution 1 and group B, received saline solution identified as solution 2.
Sponsors
Study design
Masking description
Participant will receiver mouthwash solution with labeled number, they will not know which solution will inside. Care provider - The research that will collect clinical parameter wil be different for researcher that will do the treatment. Investigator will not have contact with treatment.
Intervention model description
Thirty patients with gingivitis ages18 to 30 year with a probing depth of at most 3 mm and at least 20 teeth will select and evaluate at baseline and after 4 weeks. The periodontal clinical parameters will verify: plaque index (PI), gingival index (GI) and Simplified Oral Hygiene Index (OHIS). After evaluation of the clinical parameters, the patients will randomly allocated into two groups of 15 individuals to rinse with antimicrobials twice a day for a period of four weeks. Group A, received 0.12% chlorhexidine antimicrobian in a vial previously identified as solution 1 and group B, received saline solution identified as solution 2.
Eligibility
Inclusion criteria
* Presence of gingivitis * Probing depth (PD) with maximum 3 mm * Minimum of 20 teeth * Age between 18 and 30 years old
Exclusion criteria
* Patients with periodontal disease (PD ≥ 4mm with clinical attachment loss) * Diabetes * Osteoporosis * Pregnant or lactating females * Smokers * Users of immune suppressive medication * Phenytoin or cyclosporine * Calcium channel blockers * Antibiotics * Nonsteroidal anti-inflammatory drugs * HIV+ or AIDS
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Plaque Index | 30 days | Check the biofilm as Ainano & Bay 1975 index, Higher levels means worse. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Gingival Index | 30 days | Check the biofilm as Ainano & Bay 1975 index, Higher levels means worse. |
Countries
Brazil